Approved! Concerning these five new crown treatment drugs, Hubei this enterprise accounted for two
Read Time:52 Second
In order to further improve the production expansion and supply of symptomatic treatment drugs for new coronavirus infections, recently, the State Drug Administration approved five varieties of additional applications related to production and capacity expansion, including ibuprofen tablets, through a fast review channel. Among them, ibuprofen production capacity can be increased by 14 million tablets (bags) per day.
Combing found that the list of announced drugs contains ibuprofen tablets and ibuprofen granules produced by Hubei Hendi Pharmaceutical Co. It is understood that Hubei Hendi Pharmaceutical Co., Ltd. is a local listed company. The company is one of the world’s six largest manufacturers of ibuprofen API, as well as the API suppliers of more than 30 world-renowned pharmaceutical companies such as Pfizer, Johnson & Johnson, Sanofi, GlaxoSmithKline, etc. On December 9, 2022, at the Conference on High Quality Development of the Large Health Industry and the 7th China Pharmaceutical R&D-Innovation Summit. Ltd. was awarded the title of “Top 20 Pharmaceutical CDMO Enterprises in China 2022”.
Annexes are as follows.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
Average Rating